I think that's the good part of this forum. Being able to have different opinions.
I am also a dissenter (my view: There is so much HBSAg, empty spheres, RNA-packed spheres and traditional DNA-packed HBV viruses. If the immune system is meant to single out infected cells and destroy them and the number of these gazillion particles has to be brought down. I am not sure if I read about this or phantasize here, but would extra-cellular HBsAg be an antibody sink?, preventing them to reach infected cells [if HBsAg is presented on MHC-I there])*
* from my answer you can deduce that I have no position in a HCB-focused stock at the moment
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.